Nuvectis Pharma is terminating development of NXP800 in ovarian cancer after it failed to show promise in a Phase Ia/Ib study ...

High-risk factors for endometrial or uterine cancer were obesity, hypertension, and those who underwent hormone replacement ...

Apollo Cancer Centre launches End-O Check for early detection of ovarian and endometrial cancers, emphasizing awareness and ...

Mysuru: Surgery is the primary treatment for two of the most prevalent gynaecological cancers, Apollo BGS Hospitals surgical oncologist Dr Y Ramya sai.

According to SNS Insider, Global Ovarian Cancer Diagnostics Market Growth is Driven by Rising Awareness, Technological Advancements in Imaging & Biomarker.Austin, Aug. 04, 2025 (GLOBE NEWSWIRE) -- ...

Investigators discuss how their findings on ovarian cancer mortality trends can guide earlier detection and prevention ...

CHENNAI: Apollo Cancer Centre (ACC) and Apollo Proton Cancer Centre (APCC) have launched ‘End-O Check’, a specialised ...

The Ovarian Cancer Coalition of Central SC (OCC) will hold the annual butterfly release for ovarian cancer September 18, 2025 ...

While ovarian cancer is known as the 'silent killer' due to its vague symptoms, it's essential to be aware of the signs - here, a gynaecological oncologist explains more.

Indian women are urged to recognize subtle health changes for early detection of serious conditions like ovarian cancer, PCOS, and thyroid disorders. Symptoms such as persistent bloating, unexplained ...

After ovary removal to prevent cancer, the sudden loss of estrogen reshaped my health and life, showing the need for better ...

O Check,’ a targeted early detection initiative aimed at women aged 45 and above. The program emphasizes screening for endometrial and ovarian cancers through awareness, proactive diagnostics like ...